Transgene Reports Business Update and Q3 2023 Financial Position

Regulatory News:


Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update and its financial position for the quarter ending September...

Related Keywords

Transgene Euronext ,Astrazeneca ,Twitter ,Linkedin ,Reports Business Update ,Euronext Paris ,Tasly Biopharmaceuticals ,Artificial Intelligence ,Risk Factors ,Universal Registration Document ,